Skip to content

ABSL Pure Value Review & Pharma Funds Update

 

ABSL Pure Value fund, one of the investor favorite funds, now gaining momentum. It has 43% exposure to top-performing stocks, helping it gain 21% in the last 3 months. One can look at investing in this fund, which is carrying about 4.5% risk on today’s NAV.

Pharma Funds continue their dream run, having added 2% more profits to their already locked 15% profits. Risks on MF NAV’s have started coming down from 5 to 4.50%, this is both a caution and an advantage. Play safe.

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on whatsapp
Share on email

Book An Enquiry